UB Paderborn / Katalog / Suche / in CDI

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies

The Journal of molecular diagnostics : JMD, 2016-07, Vol.18 (4), p.507-515

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

Archives of pathology & laboratory medicine (1976), 2017-06, Vol.141 (6), p.751-758

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.823-859

2013

Link zum Volltext

Verfügbarkeit prüfen

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges

Neuro-oncology (Charlottesville, Va.), 2019-02, Vol.21 (2), p.167-178

2019

Link zum Volltext

Verfügbarkeit prüfen

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Clinical cancer research, 2020-06, Vol.26 (11), p.2565-2572

2020

Link zum Volltext

Verfügbarkeit prüfen

Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing

The Journal of molecular diagnostics : JMD, 2017, Vol.19 (1), p.84-91

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Archives of pathology & laboratory medicine (1976), 2013-06, Vol.137 (6), p.828-860

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology

Journal of clinical oncology, 2017-03, Vol.35 (9), p.929-933

2017

Link zum Volltext

Verfügbarkeit prüfen

Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

Journal of thoracic oncology, 2013-02, Vol.8 (2), p.179-184

2013

Link zum Volltext

Verfügbarkeit prüfen

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

Nucleic acids research, 2015-02, Vol.43 (3), p.e19

2015

Link zum Volltext

Verfügbarkeit prüfen

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Cancer cell, 2010-01, Vol.17 (1), p.77-88

2010

Link zum Volltext

Verfügbarkeit prüfen

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

British journal of cancer, 2020-02, Vol.122 (4), p.555-563

2020

Link zum Volltext

Verfügbarkeit prüfen

Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.322-328

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation for High-risk HPV in Squamous Cell Carcinomas and Precursor Lesions Arising in the Conjunctiva and Lacrimal Sac

The American journal of surgical pathology, 2016-04, Vol.40 (4), p.519-528

2016

Link zum Volltext

Verfügbarkeit prüfen

Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants

Modern pathology, 2021-02, Vol.34 (2), p.457-468

2021

Link zum Volltext

Verfügbarkeit prüfen

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays

Archives of pathology & laboratory medicine (1976), 2019-04, Vol.143 (4), p.463-471

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma

Clinical cancer research, 2014-12, Vol.20 (24), p.6551-6558

2014

Link zum Volltext

Verfügbarkeit prüfen

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

Cancer, 2009-02, Vol.117 (1), p.67-72

2009

Link zum Volltext

Verfügbarkeit prüfen

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.496-503

2016

Link zum Volltext

Verfügbarkeit prüfen

Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology

Diagnostic cytopathology, 2016-12, Vol.44 (12), p.1000-1009

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-03, Vol.25 (7), p.760-766

2007

Link zum Volltext

Verfügbarkeit prüfen

Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

IEEE transactions on medical imaging, 2022-04, Vol.41 (4), p.757-770

2022

Link zum Volltext
IEEE_Xplore

Cost-Effectiveness of Multiplexed Predictive Biomarker Screening in Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2015-04, Vol.10 (4), p.586-594

2015

Link zum Volltext

Verfügbarkeit prüfen

Utility of Histologic and Histochemical Screening for 16S Ribosomal RNA Gene Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue for Bacterial Endocarditis

American journal of clinical pathology, 2019-09, Vol.152 (4), p.431-437

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology

Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas

Evaluation for High-risk HPV in Squamous Cell Carcinomas and Precursor Lesions Arising in the Conjunctiva and Lacrimal Sac

Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays

Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung

Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology

Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

Cost-Effectiveness of Multiplexed Predictive Biomarker Screening in Non-Small-Cell Lung Cancer

Utility of Histologic and Histochemical Screening for 16S Ribosomal RNA Gene Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue for Bacterial Endocarditis

Suchergebnisse filtern